IFNG and osteosarcoma: Pahl et al. observed that M1 macrophages, activated by LPS and IFN-γ, effectively suppress osteosarcoma cell proliferation, demonstrating an advantageous role in osteosarcoma immunotherapy (Pahl et al., 2014).